Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 6.668.638.02-4.12-4.15

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 6.66 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20256.66
Mar20248.63
Mar20238.02
Mar2022-4.12
Mar2021-4.15

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2025 6.66
-22.83
Mar2024 8.63
7.61
Mar2023 8.02
Positive
Mar2022 -4.12
Negative
Mar2021 -4.15 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹204.3 Cr -3% 1% -44.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-3%

1%

-44.1%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses